Please assess the completion status of the following clinical trial:

Trial Title: Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Infertile women aged 18-40 undergoing their first IVF/ICSI cycle that are in good physical and mental health and that have been diagnosed with problems in the fallopian tubes, mild endometriosis or have partners with decreased sperm quality.~* The participants must have a regular menstrual cycle, a normal uterus and 2 normal ovaries.~* The allowed body mass index is 17.5-32 Kg/m\^2.~Exclusion Criteria:~* Women with very high ovarian reserve, strong preference for either treatment, severe endometriosis, history of repeated miscarriage, couples with known problems in the chromosomes, history or high risk of producing blood cloths, women known to have chronic diseases, women recently participating in trials with non-registered drugs.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- FE 999049 + GnRH agonist (GONAPEPTYL) (Type: EXPERIMENTAL): None
- FE 999049 + GnRH antagonist (CETROTIDE) (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).